These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 30834539

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Enzyme replacement therapy initiated in adulthood: Findings from the mucopolysaccharidosis VI Clinical Surveillance Program.
    Lampe C, Harmatz PR, Parini R, Sharma R, Teles EL, Johnson J, Sivam D, Sisic Z.
    Mol Genet Metab; 2019 Aug; 127(4):355-360. PubMed ID: 31324526
    [Abstract] [Full Text] [Related]

  • 3. Natural history and galsulfase treatment in mucopolysaccharidosis VI (MPS VI, Maroteaux-Lamy syndrome)--10-year follow-up of patients who previously participated in an MPS VI Survey Study.
    Giugliani R, Lampe C, Guffon N, Ketteridge D, Leão-Teles E, Wraith JE, Jones SA, Piscia-Nichols C, Lin P, Quartel A, Harmatz P.
    Am J Med Genet A; 2014 Aug; 164A(8):1953-64. PubMed ID: 24764221
    [Abstract] [Full Text] [Related]

  • 4. The effect of galsulfase enzyme replacement therapy on the growth of patients with mucopolysaccharidosis VI (Maroteaux-Lamy syndrome).
    Harmatz P, Hendriksz CJ, Lampe C, McGill JJ, Parini R, Leão-Teles E, Valayannopoulos V, Cole TJ, Matousek R, Graham S, Guffon N, Quartel A, MPS VI Study Group.
    Mol Genet Metab; 2017 Sep; 122(1-2):107-112. PubMed ID: 28457718
    [Abstract] [Full Text] [Related]

  • 5. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI.
    Brunelli MJ, Atallah ÁN, da Silva EM.
    Cochrane Database Syst Rev; 2016 Mar 04; 3():CD009806. PubMed ID: 26943923
    [Abstract] [Full Text] [Related]

  • 6. Retrospective chart review of urinary glycosaminoglycan excretion and long-term clinical outcomes of enzyme replacement therapy in patients with mucopolysaccharidoses.
    Jones SA, Marsden D, Koutsoukos T, Sniadecki J, Tylee K, Phillippo S, Kakkis E.
    Mol Genet Metab; 2020 Aug 04; 130(4):255-261. PubMed ID: 32563631
    [Abstract] [Full Text] [Related]

  • 7. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis type VI.
    Brunelli MJ, Atallah ÁN, da Silva EM.
    Cochrane Database Syst Rev; 2021 Sep 17; 9(9):CD009806. PubMed ID: 34533215
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Design, baseline characteristics, and early findings of the MPS VI (mucopolysaccharidosis VI) Clinical Surveillance Program (CSP).
    Hendriksz CJ, Giugliani R, Harmatz P, Lampe C, Martins AM, Pastores GM, Steiner RD, Leão Teles E, Valayannopoulos V, CSP Study Group.
    J Inherit Metab Dis; 2013 Mar 17; 36(2):373-84. PubMed ID: 22127392
    [Abstract] [Full Text] [Related]

  • 10. Long-term outcomes of patients with mucopolysaccharidosis VI treated with galsulfase enzyme replacement therapy since infancy.
    Garcia P, Phillips D, Johnson J, Martin K, Randolph LM, Rosenfeld H, Harmatz P.
    Mol Genet Metab; 2021 May 17; 133(1):100-108. PubMed ID: 33775523
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics, pharmacokinetics and biodistribution of recombinant human N-acetylgalactosamine 4-sulfatase after 6months of therapy in cats using different IV infusion durations.
    Ruane T, Haskins M, Cheng A, Wang P, Aguirre G, Knox VW, Qi Y, Tompkins T, O'Neill CA.
    Mol Genet Metab; 2016 Feb 17; 117(2):157-63. PubMed ID: 26776148
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Enzyme replacement therapy with galsulfase for mucopolysaccharidosis VI: clinical facts and figures.
    Harmatz P.
    Turk J Pediatr; 2010 Feb 17; 52(5):443-9. PubMed ID: 21434527
    [Abstract] [Full Text] [Related]

  • 18. Enzyme replacement therapy with galsulfase in 34 children younger than five years of age with MPS VI.
    Horovitz DD, Magalhães TS, Acosta A, Ribeiro EM, Giuliani LR, Palhares DB, Kim CA, de Paula AC, Kerstenestzy M, Pianovski MA, Costa MI, Santos FC, Martins AM, Aranda CS, Correa Neto J, Holanda GB, Cardoso L, da Silva CA, Bonatti RC, Ribeiro BF, Rodrigues Mdo C, Llerena JC.
    Mol Genet Metab; 2013 May 17; 109(1):62-9. PubMed ID: 23535281
    [Abstract] [Full Text] [Related]

  • 19. Long-term galsulfase enzyme replacement therapy in Taiwanese mucopolysaccharidosis VI patients: A case series.
    Lin HY, Chuang CK, Wang CH, Chien YH, Wang YM, Tsai FJ, Chou YY, Lin SJ, Pan HP, Niu DM, Hwu WL, Ke YY, Lin SP.
    Mol Genet Metab Rep; 2016 Jun 17; 7():63-9. PubMed ID: 27134829
    [Abstract] [Full Text] [Related]

  • 20. Early initiation of enzyme replacement therapy for the mucopolysaccharidoses.
    Muenzer J.
    Mol Genet Metab; 2014 Feb 17; 111(2):63-72. PubMed ID: 24388732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.